Hôpital Européen Georges Pompidou - AP-HP

51 currently recruiting clinical trials
Create patient profile for matching
Phase 1 / Phase 2 Stomach and esophageal cancer Sarcoma and GIST #NCT05957367 #2024-516476-15-00
Module B Partie 2
GIST Gastrointestinal stromal tumor Locally Advanced Metastatic KIT 1 Targeted therapy
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Deciphera Pharmaceuticals, LLC
Phase 1 / Phase 2 Stomach and esophageal cancer Sarcoma and GIST #NCT05957367 #2024-516476-15-00
Module B Partie 1
GIST Gastrointestinal stromal tumor Locally Advanced Metastatic KIT PDGFRA 1 2 3 or more
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Deciphera Pharmaceuticals, LLC
Phase 1 / Phase 2 Prostate cancer #NCT07206056 #2025-521880-10-00
Adenocarcinoma Metastatic Castration-resistant 1 2 3 or more Hormone therapy
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Novartis
Phase 1 / Phase 2 Prostate cancer #NCT06353386 #2023-506288-33-00
Adenocarcinoma Metastatic Castration-resistant 1 2 3 or more Hormone therapy Hormone therapy
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Merck Sharp & Dohme LLC
Phase 1 / Phase 2 Lung cancer #NCT06710132
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic 1 2 3 or more Chemotherapy Targeted therapy
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
EMD Serono Research & Development Institute, Inc.
Phase 1 / Phase 2 Pancreas cancer #NCT06710132
Adenocarcinoma Locally Advanced Metastatic 1 2 Chemotherapy
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
EMD Serono Research & Development Institute, Inc.
Phase 1 / Phase 2 Stomach and esophageal cancer #NCT06710132
Stomach Oesogastric junction Adenocarcinoma Locally Advanced Metastatic 1 2 Chemotherapy
HER2 Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
EMD Serono Research & Development Institute, Inc.
Phase 1 Breast cancer Lung cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05403554 #2021-003808-40
Cohorte monothérapie
NSCLC (Non-Small Cell Lung Cancer) Epithelial ovarian cancer Non-squamous NSCLC Serous high grade carcinoma (HGSOC) Endometrioid carcinoma HER2 Negative HER2 Positive Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Light Chain Bioscience - Novimmune SA
Phase 1 Lung cancer Pancreas cancer Ovarian / Fallopian tubes / Peritoneum cancer #NCT05403554 #2021-003808-40
Cohorte d'association avec le pembrolizumab
NSCLC (Non-Small Cell Lung Cancer) Epithelial ovarian cancer Non-squamous NSCLC Adenocarcinoma Serous high grade carcinoma (HGSOC) Endometrioid carcinoma Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Light Chain Bioscience - Novimmune SA
Phase 1
Matches all main criterias
Hôpital Européen Georges Pompidou - AP-HP (Paris)